DHCR7 and Burkitt lymphoma: DHCR7 mutations were observed in approximately 9.8% of BL cases [116], with certain variants (T93M, N274K, L306R, E448K, and V353fs) found to be dysfunctional, failing to metabolize 7-DHC.